Cell Counting Market Size

  • Report ID: 3546
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Cell Counting Market Size

Cell Counting Market size was valued at USD 10.09 billion in 2024 and is anticipated to exceed USD 46.16 billion by the end of 2037, registering over 12.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of cell counting is evaluated at USD 11.09 billion.. The growth of the market can be attributed to the rising incidence of chronic diseases. The rising demand for biologics for the treatment of chronic illnesses is predicted to increase further in the years to come. For instance, different cell counting tools are employed during the creation of biologics. Further, an increase in the consumption of unhealthy foods, and rising stress levels among people across the globe are also expected to add to the market growth. As per estimates, more than 50% of individuals in the US had at least one chronic illness in 2018.

In addition to these, factors that are believed to fuel the market growth of cell counting include the growing popularity of cell counting instruments. For instance, the use of cell counting tools is expanding across a wide range of academic fields, including neurology, cancer biology, and immunology. Further, they are widely utilized in cancer research. Additionally, the growing technological advancements in cell counting devices are predicted to present the potential for market expansion over the projected period.


Cell Counting Market Overview
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3546
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of cell counting is evaluated at USD 11.09 billion.

The cell counting market size was valued at USD 10.09 billion in 2024 and is anticipated to exceed USD 46.16 billion by the end of 2037, registering over 12.3% CAGR during the forecast period i.e., between 2025-2037. Growing prevalence of infectious diseases, and surging incidences of target diseases such as HIV will boost the market growth.

Asia Pacific is poised to dominate majority industry share by 2037, attributed to increasing cases of cancer.

The major players in the market include Merck KgaA, Thermo Fisher Scientific Inc., Perkin Elmer Inc., Olympus Corporation, Tecan Trading AG, Abbott Laboratories, General Electric Company, Boule Diagnostics AB, Becton, Dickinson, and Company, Sysmex Corporation.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample